Ranitidine does not potentiate mediator release from human lung in vitro.
作者信息
Hughes J M, Seale J P, Temple D M
出版信息
Br J Clin Pharmacol. 1985 May;19(5):711-2. doi: 10.1111/j.1365-2125.1985.tb02702.x.
Abstract
摘要
相似文献
1
Ranitidine does not potentiate mediator release from human lung in vitro.雷尼替丁在体外不会增强人肺中介质的释放。
Br J Clin Pharmacol. 1985 May;19(5):711-2. doi: 10.1111/j.1365-2125.1985.tb02702.x.
2
Verapamil inhibits mediator release from human lung in vitro.维拉帕米在体外抑制人肺中介质的释放。
Thorax. 1983 May;38(5):386-7. doi: 10.1136/thx.38.5.386.
3
Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro.5-脂氧合酶抑制剂REV-5901对人肺组织体外白三烯和组胺释放的影响。
J Pharm Pharmacol. 1987 Apr;39(4):309-11. doi: 10.1111/j.2042-7158.1987.tb06274.x.
4
Selective inhibition by betamethasone of allergen-induced release of SRS-A from human lung.倍他米松对变应原诱导的人肺组织中慢反应物质-A释放的选择性抑制作用。
Int Arch Allergy Appl Immunol. 1982;67(3):284-6. doi: 10.1159/000233032.
5
Immunologic mediator release from rhesus and cynomolgus monkey lung.恒河猴和食蟹猴肺中免疫介质的释放
J Pharmacol Methods. 1980 Aug;4(1):59-69. doi: 10.1016/0160-5402(80)90044-3.
6
Anaphylaxis in chickens: evidence for in vivo and in vitro histamine release.鸡的过敏反应：体内和体外组胺释放的证据
Proc Soc Exp Biol Med. 1977 Dec;156(3):436-40. doi: 10.3181/00379727-156-39952.
7
8
Dopaminergic (co-mediator) modulation of release of histamine and SRS-A in the calf [proceedings].多巴胺能（共同介质）对小牛体内组胺和慢反应物质-A释放的调节[会议论文集]
Br J Pharmacol. 1976 Nov;58(3):445P.
9
Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells.雷尼替丁和法莫替丁与豚鼠离体壁细胞的相互作用。
Pharmacology. 1986;33(5):274-8. doi: 10.1159/000138226.
引用本文的文献
1
Can MiR-503 be used as a marker in diabetic patients with ischemic stroke?miR-503 能否作为糖尿病合并脑梗死患者的标志物？
BMC Endocr Disord. 2019 Apr 29;19(1):42. doi: 10.1186/s12902-019-0371-6.
2
Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.雷尼替丁。对其药效学、药代动力学特性以及在消化性溃疡疾病和其他相关疾病中的治疗应用的最新综述。
Drugs. 1989 Jun;37(6):801-70. doi: 10.2165/00003495-198937060-00003.
本文引用的文献
1
Effect of fenoterol on immunological release of leukotrienes and histamine from human lung in vitro: selective antagonism by beta-adrenoceptor antagonists.非诺特罗对人肺组织体外白三烯和组胺免疫释放的影响：β-肾上腺素能受体拮抗剂的选择性拮抗作用
Eur J Pharmacol. 1983 Nov 25;95(3-4):239-45. doi: 10.1016/0014-2999(83)90640-4.
2
Lipoxygenase products modulate histamine release in human basophils.脂氧合酶产物调节人嗜碱性粒细胞中的组胺释放。
Nature. 1981 Jul 30;292(5822):455-7. doi: 10.1038/292455a0.
3
New drugs for peptic ulcer.治疗消化性溃疡的新药。
Med J Aust. 1984 Sep 1;141(5):303-8. doi: 10.5694/j.1326-5377.1984.tb113104.x.
4
Pharmacokinetics of the H2- receptor antagonist ranitidine in man.H2受体拮抗剂雷尼替丁在人体中的药代动力学。
Br J Clin Pharmacol. 1981 Sep;12(3):411-5. doi: 10.1111/j.1365-2125.1981.tb01236.x.
5
Some in vitro and in vivo actions of the new histamine H2-receptor antagonist, ranitidine.新型组胺H2受体拮抗剂雷尼替丁的一些体外和体内作用。
Br J Pharmacol. 1981 Jan;72(1):49-54. doi: 10.1111/j.1476-5381.1981.tb09103.x.
6
The effects of the immunologic release of histamine upon human lung cyclic nucleotide levels and prostaglandin generation.组胺免疫释放对人肺环核苷酸水平及前列腺素生成的影响。
J Clin Invest. 1978 Dec;62(6):1113-21. doi: 10.1172/JCI109230.
7
The effects of the H1 and H2 antihistamines on "allergic" histamine release and its inhibition by histamine.H1和H2抗组胺药对“过敏性”组胺释放的影响及其受组胺的抑制作用。
J Pharmacol Exp Ther. 1975 Feb;192(2):441-50.
8
Effects of oral H1 and H2 receptor antagonists in asthma.口服H1和H2受体拮抗剂对哮喘的影响。
Br J Clin Pharmacol. 1979 Sep;8(3):249-51. doi: 10.1111/j.1365-2125.1979.tb01010.x.
Zotero 插件